Duearity is a Swedish medical technology company based in

Malmö Malmö (, ; da, Malmø ) is the largest city in the Swedish county (län) of Scania (Skåne). It is the third-largest city in Sweden, after Stockholm and Gothenburg, and the sixth-largest city in the Nordic region, with a municipal pop ...

. The company specialises in hardware and software for tinnitus treatment. As of May 2021, Duearity is a public company listed on the

Nasdaq First North Nasdaq First North Growth Market is a division of Nasdaq Nordic and an alternative stock exchange (legally a multilateral trading facility) for smaller companies in Europe. The market place Nya Marknaden in Stockholm changed name to First North i ...

stock exchange.Nasdaq
Listing of Duearity AB (publ), on Nasdaq First North Growth Market (203/21) , Nasdaq
accessdate: 6 december 2022Hörselbolaget Duearity till First North
Hörselbolaget Duearity till First North
, accessdate: 6 december 2022Affärsvärlden
Duearity - IPO , Affärsvärlden
, accessdate: 6 december 2022

Origins

Peter Arndt, one of Duearity's founders, was undergoing tinnitus retraining therapy (TRT) and noticed the treatment to be effective, but incompatible with daily life. Tinnitus retraining therapy is based on cognitive behavioral therapy and requires white noise to be played uninterrupted for 6-8 hours per day for 6-24 months. Wearing headphones for prolonged and uninterrupted period of time was interfering with work during daytime and with sleep during nighttime. The founders set out to find a solution that did not require headphones and did not occupy the ear canals.Digital Health Technology News
Swedish MedTech startup starts pre-sale of unique product for tinnitus treatment - Digital Health Technology News
, accessdate: 6 december 2022MedTech Magazine
Malmöbolag lanserar produkt för egenbehandling av tinnitus - MedTech Magazine
, accessdate: 6 december 2022 In 2020, a proof of concept was successfully completed and the company applied for a patent.

IPO

On 11 May 2021, the company's shares debuted on

under

ticker symbol A ticker symbol or stock symbol is an abbreviation used to uniquely identify publicly traded shares of a particular stock on a particular stock market. In short, ticker symbols are arrangements of symbols or characters (generally Latin letters ...

DEAR. The company was previously called Cochlearity, but the name was changed pre-IPO in order to avoid mixup with another medtech company.MedTech Magazine
Cochlearity blir Duearity inför börsnotering - MedTech Magazine
, accessdate: 6 december 2022 75,3% of the IPO shares were subscribed before the IPO offer was made public. Duearity’s IPO was oversubscribed by 9 times.

Products and market

Duearity is focusing its products on white noise and tinnitus retraining therapy, which has been shown to be effective in a variety of research studies. Since 2020, Duearity has been developing the world's smallest and most flexible tinnitus aid that emits white noise through bone conduction technology.BioStock
Duearity vill hjälpa personer med tinnitusbesvär - BioStock
, accessdate: 6 december 2022Duearity ska noteras på Nasdaq First North den 11 maj
Duearity ska noteras på Nasdaq First North den 11 maj
, accessdate: 6 december 2022 It is a patented medtech CE class IIa product.Svensk Patentdatabas, Träfflista
Svensk Patentdatabas, Träfflista
, accessdate: 6 december 2022PRV avser att godkänna Duearitys patentansökan
PRV avser att godkänna Duearitys patentansökan
, accessdate: 6 december 2022 It is a non-invasive device that attaches behind the ears and keeps the ear canals free. The device will be launched in Europe once it receives a

CE marking On commercial products, the letters CE (as the logo ) mean that the manufacturer or importer affirms the good's conformity with European health, safety, and environmental protection standards. It is not a quality indicator or a certificatio ...

Duearitys produkt beräknas erhålla CE-märkning i november i år
Duearitys produkt beräknas erhålla CE-märkning i november i år
, accessdate: 6 december 2022 and in the USA once it receives

FDA approval The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food ...

.Investeringsmemorandum-Duearity-AB-2022.pdf
investerarmemorandum.indd - Investeringsmemorandum-Duearity-AB-2022.pdf
, accessdate: 6 december 2022 Duearity is also developing a patented software solution for analysing tinnitus and managing its symptoms. The company observes strong interest in the solution from

researchers Research is "creative and systematic work undertaken to increase the stock of knowledge". It involves the collection, organization and analysis of evidence to increase understanding of a topic, characterized by a particular attentiveness t ...

audiologists Audiology (from Latin , "to hear"; and from Greek , ''-logia'') is a branch of science that studies hearing, balance, and related disorders. Audiologists treat those with hearing loss and proactively prevent related damage. By employing various ...

and otorhinolaryngologists. As of 2022, it is not yet available on the market.Inderes: Osakeanalyysit, mallisalkku, osakevertailu & aamukatsaus
Duearity to develop AI solution for people suffering from tinnitus , Inderes: Osakeanalyysit, mallisalkku, osakevertailu & aamukatsaus
, accessdate: 6 december 2022

References

External links

Official website
* * {{Finance links , name = Duearity AB , symbol = DEAR , bloomberg = DEAR:SS , yahoo = DEAR.ST , google = DEAR:STO

Origins

IPO

Products and market

References

External links

Further reading

See also